For the Inventor, By the Inventor

Enter assignee name

Dompé Farmaceutici S.p.a.

USPTO Granted Patents = 55

% Expired Patents = 12.7

CIPO Patents = 4

EPO Patents = 32

Trademarks = 14

Forward Citations = 229

Loading Chart...

Loading Chart...

81 inventors (with patents filed for the assignee):

Andrea Aramini (18 out of 27 patents)

Marcello Allegretti (16 out of 42 patents)

Gianluca Bianchini (16 out of 18 patents)

4. Laura Brandolini (11 out of 13 patents)

5. Samuele Lillini (8 out of 8 patents)

6. Giancarlo Tonon (7 out of 8 patents)

7. Andrea Beccari (6 out of 9 patents)

8. Roberto P Giani (5 out of 8 patents)

9. Gaetano Clavenna (5 out of 11 patents)

10. Salvatore Malandrino (4 out of 8 patents)

11. Giani P Roberto (4 out of 4 patents)

12. Parini Ettore (4 out of 4 patents)

13. Carmelo A Gandolfi (4 out of 33 patents)

14. Marco Mantovanini (4 out of 9 patents)

15. Ettore Parini (4 out of 5 patents)

Core Competencies:

Gabapentin

Ketoprofen

IL-8 Inhibitors

Nerve Growth Factor

Co-crystal

Ocular Diseases

Muscle Wasting

Diabetic Nephropathy

TRPM8 Antagonists

Bradykinin Receptor Antagonists

Pharmaceutical Formulations

Amino Acids

55 patents: Sort by Forward Citations

1. 12667549 - Synergistic admixtures of Gabapentin and Ketoprofen, pharmaceutical compositions and their medical use (2026-06-30),

2. 12662519 - NERVE GROWTH FACTOR AND METHODS OF USE THEREOF FOR NEURODEVELOPMENTAL DISABILITIES ASSOCIATED WITH NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY (2026-06-23),

3. 12582624 - Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use (2026-03-24),

4. 12558399 - Isocyclosporin A for topical treatment of ocular diseases (2026-02-24),

5. 12528760 - Co-crystal of ketoprofen and its preparation, pharmaceutical compositions comprising the same and uses thereof (2026-01-20),

6. 12521359 - Composition for the treatment of muscle wasting (2026-01-13),

7. 12491133 - Deformable container, kit and packaging (2025-12-09),

8. 12365644 - Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use (2025-07-22),

9. 12358950 - IL-17A binding peptides and medical uses thereof (2025-07-15),

10. 12285396 - Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof (2025-04-29),

11. 12268671 - IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy (2025-04-08),

12. 12186359 - Composition containing branched-chain amino acids (2025-01-07),

13. 12150933 - IL-8 inihibitors for use in the treatment of some urological disorders (2024-11-26),

14. 12133843 - IL-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections (2024-11-05),

15. 12102607 - C5aR inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain (2024-10-01),

Company Overview

Dompé Farmaceutici S.p.a., headquartered in Milan, Italy, specializes in the development and manufacturing of innovative pharmaceutical compositions. The company focuses on advanced therapeutic areas, including pain management and ocular diseases, leveraging core technologies such as Gabapentin and Ketoprofen. Dompé is also engaged in research related to IL-8 inhibitors, nerve growth factors, and treatments for conditions like muscle wasting and diabetic nephropathy, positioning itself as a key player in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

55 Patents

#41 in 20122 Milan

#162 in Italy

#12,922 in the World

Dompé Farmaceutici S.p.a.

Forward Citations = 229

81 inventors:

Andrea Aramini (18 out of 27 patents)

Marcello Allegretti (16 out of 42 patents)

Gianluca Bianchini (16 out of 18 patents)

4. Laura Brandolini (11 out of 13 patents)

5. Samuele Lillini (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dompé Farmaceutici S.p.a.. Retrieved from https://idiyas.com/company/dompe-farmaceutici

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…